Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Close this search box.

Sterile Fill-Finish

The demand for sterile fill-finish services has outpaced available capacity, leading to extended wait times and delayed clinical trials for sponsors. In response, Syngene is launching a state-of-art Sterile Fill-Finish facility, building upon our years of sterile fill formulation development expertise to develop and manufacture:

  • Pre-filled syringes
  • Sterile products in pre-sterilized vials

Syngene’s Sterile Fill-Finish facility is custom-built to meet market demand for small-scale, sterile drug products having short development timelines. Our facility offers drug substance (DS) and drug product (DP) development  and manufacturing for both small molecules and biologics.

Play Video about Syngene’s-Sterile-Fill-Finish-Facility

Syngene’s Sterile Fill-Finish facility is custom-built to meet your company’s clinical and small-scale commercial needs.

The Syngene advantage

Deciding on a partner for drug product (DP) development and clinical supply manufacturing for both small molecule and biologics is one of the most critical decisions the sponsor makes on its program. Syngene has proven its ability to consistently provide: 

  • Integrated formulation and analytical services to reduce timelines and overall costs for clinical programs from IND to registration
  • In-depth experience handling biologics and small molecules as well as products that are sensitive to light, temperature or oxygen
  • Expertise in technology transfer and trouble-shooting during batch manufacturing and successful completion of cGMP batches
  • Robust quality management systems and efficient data processing tools for high-quality data on time and in budget
  • A consultative, fit-for-purpose service for critical decisions at each stage of development
  • Collaborative, solution-oriented approach to solve complex problems in CMC services
  • Program management support to keep internal teams aligned on deliverables and timelines and our sponsors well-informed on progress

Process flow

Our sterile formulation development experience

We are a full value chain CDMO partner to global biopharma

  • End to end services from GLP-Tox batches to clinical supplies, process scale up and cGMP manufacturing of sterile drug products for biologics and small molecules
  • Ability to seamlessly integrate between DS development, DP development and cGMP manufacturing of both DS and DP

Syngene offers more than just fill/finish of sterile injectables. Strong technical capabilities and broad parenteral resources help us align with your company’s clinical/commercial objectives and our shared goal of “putting science to work”

Brochure: Sterile Fill-Finish facility: Your integrated partner for customized clinical supplies

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details